NCT07716917
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07716917
Title Genitourinary Tumors With Sacituzumab Tirumotecan (RINGQUEST)
Acronym RINGQUEST
Recruitment Not yet recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Alianza multidisciplinar para la investigación de los tumores genitourinarios -GUARD
Indications
Therapies
Age Groups: adult | senior
Covered Countries ESP


No variant requirements are available.